27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Atherosclerosis affects calcium signalling in endothelial cells from apolipoprotein E knockout mice before plaque formation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Little is known about how hypercholesterolaemia affects Ca 2+ signalling in the vasculature of ApoE −/− mice, a model of atherosclerosis. Our objectives were therefore to determine (i) if hypercholesterolaemia alters Ca 2+ signalling in aortic endothelial cells before overt atherosclerotic lesions occur, (ii) how Ca 2+ signals are affected in older plaque-containing mice, and (iii) whether Ca 2+ signalling changes were translated into contractility differences. Using confocal microscopy we found agonist-specific Ca 2+ changes in endothelial cells. ATP responses were unchanged in ApoE −/− cells and methyl-β-cyclodextrin, which lowers cholesterol, was without effect. In contrast, Ca 2+ signals to carbachol were significantly increased in ApoE −/− cells, an effect methyl-β-cyclodextrin reversed. Ca 2+ signals were more oscillatory and store-operated Ca 2+ entry decreased as mice aged and plaques formed. Despite clearly increased Ca 2+ signals, aortic rings pre-contracted with phenylephrine had impaired relaxation to carbachol. This functional deficit increased with age, was not related to ROS generation, and could be partially rescued by methyl-β-cyclodextrin. In conclusion, carbachol-induced calcium signalling and handling are significantly altered in endothelial cells of ApoE −/− mice before plaque development. We speculate that reduction in store-operated Ca 2+ entry may result in less efficient activation of eNOS and thus explain the reduced relaxatory response to CCh, despite the enhanced Ca 2+ response.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          Cytokines in atherosclerosis: pathogenic and regulatory pathways.

          Atherosclerosis is a chronic disease of the arterial wall where both innate and adaptive immunoinflammatory mechanisms are involved. Inflammation is central at all stages of atherosclerosis. It is implicated in the formation of early fatty streaks, when the endothelium is activated and expresses chemokines and adhesion molecules leading to monocyte/lymphocyte recruitment and infiltration into the subendothelium. It also acts at the onset of adverse clinical vascular events, when activated cells within the plaque secrete matrix proteases that degrade extracellular matrix proteins and weaken the fibrous cap, leading to rupture and thrombus formation. Cells involved in the atherosclerotic process secrete and are activated by soluble factors, known as cytokines. Important recent advances in the comprehension of the mechanisms of atherosclerosis provided evidence that the immunoinflammatory response in atherosclerosis is modulated by regulatory pathways, in which the two anti-inflammatory cytokines interleukin-10 and transforming growth factor-beta play a critical role. The purpose of this review is to bring together the current information concerning the role of cytokines in the development, progression, and complications of atherosclerosis. Specific emphasis is placed on the contribution of pro- and anti-inflammatory cytokines to pathogenic (innate and adaptive) and regulatory immunity in the context of atherosclerosis. Based on our current knowledge of the role of cytokines in atherosclerosis, we propose some novel therapeutic strategies to combat this disease. In addition, we discuss the potential of circulating cytokine levels as biomarkers of coronary artery disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

            To test the hypothesis that nitric oxide (NO) limits endothelial activation, we treated cytokine-stimulated human saphenous vein endothelial cells with several NO donors and assessed their effects on the inducible expression of vascular cell adhesion molecule-1 (VCAM-1). In a concentration-dependent manner, NO inhibited interleukin (IL)-1 alpha-stimulated VCAM-1 expression by 35-55% as determined by cell surface enzyme immunoassays and flow cytometry. This inhibition was paralleled by reduced monocyte adhesion to endothelial monolayers in nonstatic assays, was unaffected by cGMP analogues, and was quantitatively similar after stimulation by either IL-1 alpha, IL-1 beta, IL-4, tumor necrosis factor (TNF alpha), or bacterial lipopolysaccharide. NO also decreased the endothelial expression of other leukocyte adhesion molecules (E-selectin and to a lesser extent, intercellular adhesion molecule-1) and secretable cytokines (IL-6 and IL-8). Inhibition of endogenous NO production by L-N-monomethyl-arginine also induced the expression of VCAM-1, but did not augment cytokine-induced VCAM-1 expression. Nuclear run-on assays, transfection studies using various VCAM-1 promoter reporter gene constructs, and electrophoretic mobility shift assays indicated that NO represses VCAM-1 gene transcription, in part, by inhibiting NF-kappa B. We propose that NO's ability to limit endothelial activation and inhibit monocyte adhesion may contribute to some of its antiatherogenic and antiinflammatory properties within the vessel wall.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Role of caveolae and caveolins in health and disease.

              Although they were discovered more than 50 years ago, caveolae have remained enigmatic plasmalemmal organelles. With their characteristic "flasklike" shape and virtually ubiquitous tissue distribution, these interesting structures have been implicated in a wide range of cellular functions. Similar to clathrin-coated pits, caveolae function as macromolecular vesicular transporters, while their unique lipid composition classifies them as plasma membrane lipid rafts, structures enriched in a variety of signaling molecules. The caveolin proteins (caveolin-1, -2, and -3) serve as the structural components of caveolae, while also functioning as scaffolding proteins, capable of recruiting numerous signaling molecules to caveolae, as well as regulating their activity. That so many signaling molecules and signaling cascades are regulated by an interaction with the caveolins provides a paradigm by which numerous disease processes may be affected by ablation or mutation of these proteins. Indeed, studies in caveolin-deficient mice have implicated these structures in a host of human diseases, including diabetes, cancer, cardiovascular disease, atherosclerosis, pulmonary fibrosis, and a variety of degenerative muscular dystrophies. In this review, we provide an in depth summary regarding the mechanisms by which caveolae and caveolins participate in human disease processes.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cell Calcium
                Cell Calcium
                Cell Calcium
                Elsevier
                0143-4160
                1532-1991
                1 March 2014
                March 2014
                : 55
                : 3
                : 146-154
                Affiliations
                [0005]Department of Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
                Author notes
                [* ]Corresponding author at: Department of Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Centre for Women's Health Research, Liverpool Women's Hospital, Crown Street, Liverpool L8 7SS, United Kingdom. Tel.: +44 0151 7959814. cprender@ 123456liv.ac.uk
                Article
                S0143-4160(14)00034-7
                10.1016/j.ceca.2014.02.012
                4024193
                24630173
                80fa5daa-1aa9-41ca-b39d-01c11f919bf3
                © 2014 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).

                History
                : 3 December 2013
                : 20 January 2014
                : 13 February 2014
                Categories
                Article

                Molecular biology
                apoe−/−, apolipoprotein e knockout,auc, area under the curve,cch, carbachol,mcd, methyl-β-cyclodextrin,ros, reactive oxygen species,soce, store-operated ca2+ entry,whhl rabbits, watanabe heritable hyperlipidaemic rabbits,wt, wildtype,apolipoprotein-e knockout mice,hypercholesterolaemia,endothelium,calcium signalling

                Comments

                Comment on this article